1-2 of 2
Thomas Grogan, MD
Close
Sort by
Journal Articles

An Update of a Phase II Trial of CHOP Followed by Tositumomab/Iodine I-131 Tositumomab (Bexxar®) for Front-Line Treatment of Advanced Stage, Follicular Lymphoma: Southwest Oncology Group Protocol 9911.

Oliver W. Press, MD, PhD, Joseph Unger, David Maloney, MD, PhD, Rita M. Braziel, MD, Michael LeBlanc, PhD, Thomas Grogan, MD, Thomas P. Miller, MD, Richard I. Fisher, MD
Journal: Blood
Blood (2005) 106 (11): 352.
https://doi.org/10.1182/blood.V106.11.352.352
Published: 2005
Journal Articles

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Andreas Zettl, MD, Silvia Bea, George Wright, PhD, Itziar Salaverria, Philipp Jehn, German Ott, MD, Wing-Chung Chan, MD, Elaine Jaffe, MD, Dennis Weisenburger, MD, Timothy Greiner, MD, James Armitage, MD, Randy Gascoyne, MD, Joseph Connors, MD, Thomas Grogan, MD, Thomas Miller, MD, Richard Fisher, MD, Jan Delabie, MD, Stein Kvaloy, MD, Hans Konrad Mueller-Hermelink, MD, Christof Burek, Victor Moreno, Emilio Montserrat, MD, Wyndham Wilson, MD, Louis Staudt, MD, PhD, Andreas Rosenwald, MD, Elias Campo, for the Leukemia Lymphoma Molecular Profiling Project
Journal: Blood
Blood (2004) 104 (11): 415.
https://doi.org/10.1182/blood.V104.11.415.415
Published: 2004